Evaluation of tri‐ponderal mass index in predicting metabolic associated fatty liver disease in obese children

Documenti analoghi

• The correlation of apolipoprotein B and apolipoprotein A1 with metabolic dysfunction‐associated steatotic liver disease in children and adolescents with obesity
  di: Xiao‐Yan Shi, et al.
  Pubblicazione: (2025)
• Ability of triglyceride‐glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity
  di: Procolo Di Bonito, et al.
  Pubblicazione: (2025)
• The association between methimazole tapering and intractable Graves' disease in children
  di: Sung Eun Kim, et al.
  Pubblicazione: (2024)
• Neurogenic Appendicopathy in Pediatric Appendectomies During the COVID‐19 Era: A Retrospective Analysis of Histologically Negative Cases
  di: Yavuz Yilmaz, et al.
  Pubblicazione: (2026)
• Prevalence of non‐alcoholic fatty liver disease and its association with different combinations of weight status and metabolic abnormalities in children aged 6–18 years
  di: Peiyu Ye, et al.
  Pubblicazione: (2026)